PLATFORM at 90 days: Evaluating the clinical utility of FFRCT

The advancement that took place in assessing fractional flow reserve (FFR) using various competing modalities led to numerous research trials to evaluate the clinical impact of each. Among those trials is the recently published PLATFORM study. The data was designed to compare two clinical scenarios;...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharabish, Ahmed, ElGuindy, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2016
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547498/
https://www.ncbi.nlm.nih.gov/pubmed/29043269
http://dx.doi.org/10.21542/gcsp.2016.22
_version_ 1783255703694082048
author Kharabish, Ahmed
ElGuindy, Ahmed
author_facet Kharabish, Ahmed
ElGuindy, Ahmed
author_sort Kharabish, Ahmed
collection PubMed
description The advancement that took place in assessing fractional flow reserve (FFR) using various competing modalities led to numerous research trials to evaluate the clinical impact of each. Among those trials is the recently published PLATFORM study. The data was designed to compare two clinical scenarios; a combination of computed fluid dynamics with computed tomographic angiography (CTA-guided strategy) in non-obstructive coronary artery disease (CAD) on one arm, compared to the standard practice representing the other clinical arm. The study’s results were evaluated for further evidence and clinical insights.
format Online
Article
Text
id pubmed-5547498
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Magdi Yacoub Heart Foundation
record_format MEDLINE/PubMed
spelling pubmed-55474982017-10-17 PLATFORM at 90 days: Evaluating the clinical utility of FFRCT Kharabish, Ahmed ElGuindy, Ahmed Glob Cardiol Sci Pract Lessons from the Trials The advancement that took place in assessing fractional flow reserve (FFR) using various competing modalities led to numerous research trials to evaluate the clinical impact of each. Among those trials is the recently published PLATFORM study. The data was designed to compare two clinical scenarios; a combination of computed fluid dynamics with computed tomographic angiography (CTA-guided strategy) in non-obstructive coronary artery disease (CAD) on one arm, compared to the standard practice representing the other clinical arm. The study’s results were evaluated for further evidence and clinical insights. Magdi Yacoub Heart Foundation 2016-09-30 /pmc/articles/PMC5547498/ /pubmed/29043269 http://dx.doi.org/10.21542/gcsp.2016.22 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lessons from the Trials
Kharabish, Ahmed
ElGuindy, Ahmed
PLATFORM at 90 days: Evaluating the clinical utility of FFRCT
title PLATFORM at 90 days: Evaluating the clinical utility of FFRCT
title_full PLATFORM at 90 days: Evaluating the clinical utility of FFRCT
title_fullStr PLATFORM at 90 days: Evaluating the clinical utility of FFRCT
title_full_unstemmed PLATFORM at 90 days: Evaluating the clinical utility of FFRCT
title_short PLATFORM at 90 days: Evaluating the clinical utility of FFRCT
title_sort platform at 90 days: evaluating the clinical utility of ffrct
topic Lessons from the Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547498/
https://www.ncbi.nlm.nih.gov/pubmed/29043269
http://dx.doi.org/10.21542/gcsp.2016.22
work_keys_str_mv AT kharabishahmed platformat90daysevaluatingtheclinicalutilityofffrct
AT elguindyahmed platformat90daysevaluatingtheclinicalutilityofffrct

Ejemplares similares